Search Result
List
2015-07-01 - 2020-12-31
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
7Sites
Terminated7Sites
Division of Thoracic Medicine
Division of Thoracic Medicine
2018-09-01 - 2022-03-31
Phase III
-
Condition/Disease
Severe eosinophilic leukocyte asthma
-
Test Drug
Benralizumab
Participate Sites
8Sites
Recruiting8Sites
Division of Thoracic Medicine
Division of Thoracic Medicine
2018-01-17 - 2020-04-30
Phase I
-
Condition/Disease
Advanced Refractory Solid Tumors
-
Test Drug
T-1101 (Tosylate)
Participate Sites
5Sites
Suspended4Sites
Division of Hematology & Oncology
2015-06-01 - 2018-09-30
Phase II
-
Condition/Disease
non-alcoholic fatty liver disease (NAFLD)
-
Test Drug
JKB-122
Participate Sites
7Sites
Terminated7Sites
2017-09-30 - 2022-09-30
Phase I
-
Condition/Disease
Patients with Advanced Solid Tumors Refractory to Standard Therapy
-
Test Drug
HLX06
Participate Sites
3Sites
Terminated3Sites
Division of Hematology & Oncology
2016-03-01 - 2026-09-30
Phase III
-
Condition/Disease
-
Test Drug
Participate Sites
4Sites
Recruiting3Sites
Division of Hematology & Oncology
2016-06-01 - 2017-04-01
Phase II
-
Condition/Disease
-
Test Drug
Participate Sites
2Sites
Terminated2Sites
Division of Thoracic Medicine
2017-07-01 - 2020-03-31
Phase II
-
Condition/Disease
Metastatic Triple Negative Breast Cancer
-
Test Drug
Olaparib (AZD2281), AZD6738 and AZD1775
Participate Sites
10Sites
Terminated9Sites
Division of General Internal Medicine
2017-06-01 - 2019-12-31
Phase III
-
Condition/Disease
Alzheimer's Disease
-
Test Drug
Elenbecestat (E2609)
Participate Sites
13Sites
Terminated11Sites
2017-09-01 - 2019-10-31
Phase III
-
Condition/Disease
Hospital-acquired Bacterial Pneumonia, Ventilator-associatedBacterial Pneumonia, or Healthcare-associated BacterialPneumonia Caused by Gram-negative Pathogens
-
Test Drug
S-649266
Participate Sites
4Sites
Terminated4Sites
Division of Thoracic Medicine
Division of Infectious Disease
